BlackRock Capital Allocation Trust (BCAT) is a strategically managed investment vehicle designed for institutional investors seeking diversified exposure to global equities and fixed-income markets. Leveraging BlackRock's unparalleled market insights and extensive research capabilities, BCAT employs a dynamic investment approach that prioritizes effective capital allocation across various asset classes. This adaptability enables the trust to respond promptly to shifting market conditions, while its disciplined investment practices aim to deliver attractive risk-adjusted returns. As a result, BCAT presents a compelling option for investors looking to achieve both sustainable income and capital appreciation.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 0.94 |
| Price-to-Sales (TTM) | 6.71 |
| EV/Revenue | 6.71 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $104.78M |
| Float | 0 |
| % Insiders | 0.01% |
| % Institutions | 20.27% |